Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 61 | 2025 | 700 | 8.650 |
Why?
|
| Tissue Scaffolds | 50 | 2025 | 435 | 7.560 |
Why?
|
| Regeneration | 9 | 2023 | 179 | 2.260 |
Why?
|
| Extracellular Matrix | 13 | 2025 | 260 | 1.950 |
Why?
|
| Hydrogels | 14 | 2025 | 127 | 1.930 |
Why?
|
| Muscle, Skeletal | 10 | 2020 | 568 | 1.920 |
Why?
|
| Collagen | 15 | 2020 | 239 | 1.910 |
Why?
|
| Polyesters | 16 | 2019 | 78 | 1.880 |
Why?
|
| Biocompatible Materials | 21 | 2024 | 242 | 1.860 |
Why?
|
| Animals | 66 | 2025 | 8544 | 1.860 |
Why?
|
| Stem Cells | 11 | 2025 | 331 | 1.620 |
Why?
|
| Bioprosthesis | 4 | 2023 | 62 | 1.470 |
Why?
|
| Blood Vessel Prosthesis | 9 | 2023 | 87 | 1.460 |
Why?
|
| Regenerative Medicine | 5 | 2024 | 219 | 1.380 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2017 | 95 | 1.340 |
Why?
|
| Ear Cartilage | 4 | 2021 | 12 | 1.310 |
Why?
|
| Gelatin | 6 | 2019 | 29 | 1.280 |
Why?
|
| Myoblasts, Skeletal | 2 | 2020 | 20 | 1.230 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 803 | 1.190 |
Why?
|
| Guided Tissue Regeneration | 6 | 2020 | 39 | 1.180 |
Why?
|
| Organoids | 3 | 2025 | 99 | 1.150 |
Why?
|
| Cell Differentiation | 13 | 2025 | 484 | 1.120 |
Why?
|
| Troponin I | 4 | 2021 | 25 | 1.120 |
Why?
|
| Bone and Bones | 3 | 2025 | 99 | 1.070 |
Why?
|
| Materials Testing | 10 | 2018 | 93 | 1.060 |
Why?
|
| Drug Delivery Systems | 4 | 2025 | 112 | 1.000 |
Why?
|
| Humans | 56 | 2025 | 34474 | 0.990 |
Why?
|
| Alginates | 3 | 2023 | 52 | 0.980 |
Why?
|
| Microfluidics | 2 | 2025 | 18 | 0.970 |
Why?
|
| Microscopy, Electron, Scanning | 18 | 2020 | 106 | 0.900 |
Why?
|
| Cartilage | 1 | 2025 | 33 | 0.890 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 113 | 0.890 |
Why?
|
| Amniotic Fluid | 7 | 2019 | 86 | 0.870 |
Why?
|
| Postoperative Complications | 2 | 2020 | 849 | 0.870 |
Why?
|
| Cell Proliferation | 16 | 2020 | 628 | 0.870 |
Why?
|
| Cell Survival | 12 | 2025 | 304 | 0.860 |
Why?
|
| Polyglactin 910 | 2 | 2019 | 6 | 0.860 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 47 | 0.840 |
Why?
|
| Cells, Cultured | 18 | 2019 | 887 | 0.830 |
Why?
|
| Lactic Acid | 7 | 2014 | 59 | 0.790 |
Why?
|
| Surgical Procedures, Operative | 2 | 2021 | 79 | 0.790 |
Why?
|
| Models, Biological | 1 | 2025 | 426 | 0.780 |
Why?
|
| Wound Healing | 6 | 2023 | 190 | 0.780 |
Why?
|
| Polymers | 5 | 2016 | 71 | 0.740 |
Why?
|
| Coronary Artery Bypass | 2 | 2020 | 112 | 0.740 |
Why?
|
| Stem Cell Transplantation | 4 | 2024 | 228 | 0.730 |
Why?
|
| Osteogenesis | 8 | 2025 | 81 | 0.690 |
Why?
|
| Rats | 14 | 2020 | 1946 | 0.690 |
Why?
|
| Reperfusion Injury | 2 | 2020 | 58 | 0.670 |
Why?
|
| Swine | 11 | 2023 | 230 | 0.660 |
Why?
|
| Blood Vessels | 3 | 2010 | 60 | 0.640 |
Why?
|
| Muscular Diseases | 1 | 2020 | 25 | 0.630 |
Why?
|
| Ink | 2 | 2019 | 11 | 0.620 |
Why?
|
| Hospital Mortality | 2 | 2020 | 207 | 0.620 |
Why?
|
| Kidney | 4 | 2022 | 528 | 0.620 |
Why?
|
| Heart Diseases | 1 | 2021 | 124 | 0.620 |
Why?
|
| Nanofibers | 1 | 2019 | 7 | 0.620 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 70 | 0.610 |
Why?
|
| Skin Transplantation | 2 | 2023 | 49 | 0.560 |
Why?
|
| Mice | 22 | 2023 | 2691 | 0.550 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2017 | 62 | 0.540 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 30 | 0.540 |
Why?
|
| Body Mass Index | 1 | 2021 | 953 | 0.530 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 210 | 0.520 |
Why?
|
| Bone Regeneration | 4 | 2020 | 33 | 0.520 |
Why?
|
| Cell Adhesion | 12 | 2012 | 116 | 0.510 |
Why?
|
| Neurons | 2 | 2020 | 491 | 0.510 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2025 | 30 | 0.480 |
Why?
|
| Burns | 1 | 2017 | 103 | 0.480 |
Why?
|
| Tensile Strength | 9 | 2018 | 59 | 0.460 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1209 | 0.460 |
Why?
|
| Kidney Diseases | 1 | 2018 | 249 | 0.450 |
Why?
|
| Osteoblasts | 2 | 2006 | 44 | 0.450 |
Why?
|
| RNA | 1 | 2015 | 99 | 0.450 |
Why?
|
| Heparin | 2 | 2012 | 74 | 0.440 |
Why?
|
| Cells, Immobilized | 2 | 2014 | 22 | 0.440 |
Why?
|
| Rabbits | 7 | 2019 | 231 | 0.430 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 8 | 0.430 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 115 | 0.430 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 53 | 0.420 |
Why?
|
| Chondrocytes | 5 | 2018 | 70 | 0.420 |
Why?
|
| Cell Culture Techniques | 7 | 2016 | 177 | 0.400 |
Why?
|
| Obesity | 1 | 2021 | 1244 | 0.390 |
Why?
|
| Fibrin | 1 | 2013 | 33 | 0.390 |
Why?
|
| Trachea | 3 | 2019 | 56 | 0.380 |
Why?
|
| Rheology | 5 | 2019 | 35 | 0.380 |
Why?
|
| Female | 13 | 2025 | 21490 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 9 | 0.380 |
Why?
|
| Muramidase | 1 | 2012 | 8 | 0.370 |
Why?
|
| Time Factors | 6 | 2021 | 2352 | 0.360 |
Why?
|
| Male | 18 | 2021 | 20697 | 0.360 |
Why?
|
| Proteins | 1 | 2013 | 155 | 0.360 |
Why?
|
| Substance P | 1 | 2011 | 23 | 0.350 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 29 | 0.350 |
Why?
|
| Nanostructures | 2 | 2008 | 21 | 0.340 |
Why?
|
| Muscle Development | 3 | 2019 | 52 | 0.330 |
Why?
|
| Porosity | 7 | 2025 | 41 | 0.330 |
Why?
|
| Chondrogenesis | 2 | 2025 | 20 | 0.320 |
Why?
|
| Endothelial Cells | 5 | 2014 | 203 | 0.310 |
Why?
|
| Skin | 2 | 2023 | 222 | 0.310 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2019 | 183 | 0.300 |
Why?
|
| Absorbable Implants | 2 | 2013 | 27 | 0.300 |
Why?
|
| Polyglycolic Acid | 5 | 2013 | 33 | 0.300 |
Why?
|
| Neurites | 2 | 2013 | 11 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 2 | 2024 | 118 | 0.290 |
Why?
|
| Transplantation | 1 | 2008 | 13 | 0.280 |
Why?
|
| Cattle | 6 | 2015 | 118 | 0.280 |
Why?
|
| Glycolates | 2 | 2005 | 7 | 0.270 |
Why?
|
| Feasibility Studies | 2 | 2020 | 323 | 0.270 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 36 | 0.260 |
Why?
|
| Spheroids, Cellular | 2 | 2025 | 39 | 0.260 |
Why?
|
| Intestine, Small | 2 | 2006 | 43 | 0.260 |
Why?
|
| Cell Line | 9 | 2019 | 476 | 0.260 |
Why?
|
| Intestinal Mucosa | 2 | 2006 | 75 | 0.260 |
Why?
|
| Polycarboxylate Cement | 2 | 2004 | 2 | 0.250 |
Why?
|
| Surface Properties | 6 | 2010 | 38 | 0.250 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 772 | 0.250 |
Why?
|
| Ear Auricle | 2 | 2018 | 5 | 0.250 |
Why?
|
| Antigens, CD | 2 | 2018 | 106 | 0.250 |
Why?
|
| Neuromuscular Junction | 2 | 2020 | 76 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1118 | 0.240 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 302 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 110 | 0.240 |
Why?
|
| Silicon Dioxide | 1 | 2025 | 10 | 0.240 |
Why?
|
| Drug Carriers | 1 | 2025 | 24 | 0.230 |
Why?
|
| Nanoparticles | 1 | 2025 | 57 | 0.220 |
Why?
|
| Finite Element Analysis | 1 | 2025 | 84 | 0.220 |
Why?
|
| Bone Substitutes | 1 | 2004 | 9 | 0.220 |
Why?
|
| Cross-Linking Reagents | 3 | 2014 | 17 | 0.210 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 593 | 0.200 |
Why?
|
| Polyethylene | 1 | 2003 | 6 | 0.200 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2023 | 46 | 0.200 |
Why?
|
| Oxygen | 4 | 2022 | 152 | 0.190 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 79 | 0.190 |
Why?
|
| Sheep | 4 | 2017 | 233 | 0.190 |
Why?
|
| Collagen Type I | 3 | 2013 | 48 | 0.190 |
Why?
|
| Nerve Regeneration | 2 | 2013 | 51 | 0.190 |
Why?
|
| Tendons | 2 | 2013 | 60 | 0.180 |
Why?
|
| Chlorates | 1 | 2002 | 1 | 0.180 |
Why?
|
| Viscosity | 2 | 2018 | 26 | 0.170 |
Why?
|
| Elasticity | 2 | 2018 | 43 | 0.170 |
Why?
|
| Aged | 5 | 2021 | 10998 | 0.170 |
Why?
|
| Kinetics | 3 | 2022 | 259 | 0.170 |
Why?
|
| Pregnancy | 3 | 2020 | 1069 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 627 | 0.160 |
Why?
|
| Republic of Korea | 1 | 2020 | 12 | 0.160 |
Why?
|
| Rats, Inbred Lew | 3 | 2015 | 123 | 0.160 |
Why?
|
| Delayed-Action Preparations | 2 | 2012 | 36 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 67 | 0.160 |
Why?
|
| Middle Aged | 5 | 2021 | 12703 | 0.160 |
Why?
|
| Biomimetic Materials | 1 | 2020 | 15 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2020 | 74 | 0.160 |
Why?
|
| Bioreactors | 3 | 2024 | 61 | 0.150 |
Why?
|
| Injections | 2 | 2025 | 76 | 0.150 |
Why?
|
| Acute Disease | 1 | 2020 | 276 | 0.150 |
Why?
|
| Risk | 1 | 2020 | 325 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 114 | 0.150 |
Why?
|
| Registries | 1 | 2021 | 328 | 0.150 |
Why?
|
| ROC Curve | 1 | 2019 | 176 | 0.150 |
Why?
|
| Fibroblasts | 4 | 2020 | 120 | 0.150 |
Why?
|
| Mandibular Prosthesis | 1 | 2019 | 2 | 0.150 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 9 | 0.150 |
Why?
|
| Methacrylates | 1 | 2019 | 3 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 107 | 0.150 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 52 | 0.140 |
Why?
|
| Thrombin | 2 | 2010 | 26 | 0.140 |
Why?
|
| Algorithms | 1 | 2022 | 560 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2020 | 438 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 834 | 0.140 |
Why?
|
| Nerve Net | 1 | 2020 | 141 | 0.140 |
Why?
|
| Comorbidity | 1 | 2020 | 596 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2019 | 480 | 0.140 |
Why?
|
| Graft Survival | 2 | 2017 | 315 | 0.140 |
Why?
|
| Fibroins | 1 | 2018 | 5 | 0.140 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2018 | 202 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 87 | 0.140 |
Why?
|
| Myoblasts | 2 | 2015 | 42 | 0.140 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 66 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 97 | 0.130 |
Why?
|
| Cytokines | 1 | 2019 | 269 | 0.130 |
Why?
|
| Tissue Expansion Devices | 1 | 2017 | 12 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 189 | 0.130 |
Why?
|
| Cicatrix | 1 | 2017 | 41 | 0.130 |
Why?
|
| Bioartificial Organs | 2 | 2015 | 26 | 0.130 |
Why?
|
| Polyurethanes | 1 | 2016 | 5 | 0.130 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 65 | 0.130 |
Why?
|
| Myocardium | 1 | 2018 | 199 | 0.130 |
Why?
|
| NIH 3T3 Cells | 4 | 2011 | 44 | 0.130 |
Why?
|
| Rats, Nude | 4 | 2020 | 48 | 0.120 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 37 | 0.120 |
Why?
|
| Mice, Nude | 5 | 2020 | 290 | 0.120 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2013 | 10 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1288 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3618 | 0.120 |
Why?
|
| Sus scrofa | 2 | 2015 | 49 | 0.120 |
Why?
|
| Myostatin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2015 | 9 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 502 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 923 | 0.120 |
Why?
|
| Cell Movement | 3 | 2019 | 180 | 0.120 |
Why?
|
| Pulmonary Valve | 1 | 2015 | 12 | 0.120 |
Why?
|
| RNA Interference | 1 | 2015 | 79 | 0.120 |
Why?
|
| Glycoproteins | 1 | 2015 | 44 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2021 | 1506 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 76 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 118 | 0.110 |
Why?
|
| Prognosis | 1 | 2019 | 1603 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 515 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3812 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 61 | 0.110 |
Why?
|
| Adipogenesis | 2 | 2020 | 30 | 0.110 |
Why?
|
| Peptides | 1 | 2015 | 142 | 0.110 |
Why?
|
| PAX7 Transcription Factor | 1 | 2014 | 8 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 362 | 0.110 |
Why?
|
| Cell Division | 3 | 2004 | 99 | 0.110 |
Why?
|
| Cytoskeleton | 2 | 2013 | 20 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2014 | 143 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 270 | 0.100 |
Why?
|
| Elastic Modulus | 3 | 2019 | 28 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2015 | 194 | 0.100 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 15 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4150 | 0.100 |
Why?
|
| Poloxamer | 1 | 2013 | 4 | 0.100 |
Why?
|
| Myoglobin | 1 | 2013 | 11 | 0.100 |
Why?
|
| Carbocyanines | 1 | 2013 | 6 | 0.100 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 12 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 20 | 0.100 |
Why?
|
| Transplants | 1 | 2013 | 24 | 0.100 |
Why?
|
| Receptors, Cholinergic | 1 | 2013 | 26 | 0.100 |
Why?
|
| Risk Factors | 1 | 2021 | 4136 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 28 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 54 | 0.090 |
Why?
|
| Enzymes, Immobilized | 1 | 2012 | 4 | 0.090 |
Why?
|
| 3T3 Cells | 3 | 2002 | 14 | 0.090 |
Why?
|
| Culture Media | 1 | 2012 | 50 | 0.090 |
Why?
|
| Equipment Design | 2 | 2017 | 192 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 163 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2019 | 583 | 0.090 |
Why?
|
| Amines | 1 | 2012 | 24 | 0.090 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 29 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2012 | 71 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 101 | 0.090 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 65 | 0.090 |
Why?
|
| Heart Valves | 1 | 2011 | 16 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 24 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 57 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2011 | 23 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 35 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 251 | 0.090 |
Why?
|
| Water | 2 | 2004 | 70 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 508 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2011 | 197 | 0.080 |
Why?
|
| Infrared Rays | 2 | 2025 | 20 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2010 | 69 | 0.080 |
Why?
|
| Hardness | 2 | 2015 | 5 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1386 | 0.080 |
Why?
|
| Urinary Bladder | 2 | 2013 | 320 | 0.080 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 26 | 0.080 |
Why?
|
| Foreskin | 1 | 2009 | 8 | 0.070 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 44 | 0.070 |
Why?
|
| Elastin | 2 | 2006 | 17 | 0.070 |
Why?
|
| Cell Count | 1 | 2008 | 55 | 0.070 |
Why?
|
| Compressive Strength | 2 | 2019 | 23 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2017 | 38 | 0.070 |
Why?
|
| Hemostatics | 1 | 2006 | 13 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 191 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 34 | 0.060 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 42 | 0.060 |
Why?
|
| Lung | 1 | 2017 | 279 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 54 | 0.060 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 41 | 0.060 |
Why?
|
| Methotrexate | 1 | 2025 | 71 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 43 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 510 | 0.050 |
Why?
|
| Absorption | 1 | 2004 | 16 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 656 | 0.050 |
Why?
|
| Epidermis | 1 | 2023 | 30 | 0.050 |
Why?
|
| Cell Separation | 2 | 2015 | 93 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 98 | 0.050 |
Why?
|
| Wettability | 1 | 2003 | 2 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 7 | 0.050 |
Why?
|
| Electrodes | 1 | 2003 | 20 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 45 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 107 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 6 | 0.050 |
Why?
|
| Carbonates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Catalase | 1 | 2022 | 16 | 0.050 |
Why?
|
| Starch | 2 | 2012 | 8 | 0.050 |
Why?
|
| Biomedical Engineering | 2 | 2013 | 28 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2012 | 44 | 0.050 |
Why?
|
| Peroxides | 1 | 2022 | 32 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2002 | 4 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 36 | 0.050 |
Why?
|
| Insulin | 1 | 2023 | 394 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 33 | 0.040 |
Why?
|
| Calcium | 2 | 2013 | 343 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 103 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 265 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cues | 1 | 2019 | 65 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 22 | 0.040 |
Why?
|
| Podocytes | 1 | 2019 | 20 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 129 | 0.040 |
Why?
|
| Osteocytes | 1 | 2019 | 4 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2019 | 6 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 8 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 45 | 0.040 |
Why?
|
| Ischemia | 1 | 2020 | 119 | 0.040 |
Why?
|
| Polyethylenes | 1 | 2018 | 2 | 0.040 |
Why?
|
| Esthetics | 1 | 2018 | 10 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 116 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 83 | 0.030 |
Why?
|
| Light | 1 | 2018 | 41 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 33 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 153 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2016 | 56 | 0.030 |
Why?
|
| Oocytes | 1 | 2016 | 48 | 0.030 |
Why?
|
| Progesterone | 1 | 2016 | 112 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 156 | 0.030 |
Why?
|
| Mandible | 1 | 2016 | 39 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2015 | 13 | 0.030 |
Why?
|
| Solutions | 1 | 2015 | 41 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 39 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 47 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 47 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 67 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 102 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 77 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 18 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 75 | 0.030 |
Why?
|
| Tenascin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 74 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 9 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 82 | 0.030 |
Why?
|
| Tendon Injuries | 1 | 2013 | 40 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 45 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2013 | 2 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 7 | 0.020 |
Why?
|
| Bis-Trimethylammonium Compounds | 1 | 2013 | 1 | 0.020 |
Why?
|
| Collagenases | 1 | 2013 | 9 | 0.020 |
Why?
|
| Agrin | 1 | 2013 | 9 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2013 | 76 | 0.020 |
Why?
|
| Muscle Denervation | 1 | 2013 | 31 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 30 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2013 | 28 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2013 | 72 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 400 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2013 | 69 | 0.020 |
Why?
|
| Peroneal Nerve | 1 | 2012 | 15 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 8 | 0.020 |
Why?
|
| Axons | 1 | 2012 | 36 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 6 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 39 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 86 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2012 | 3 | 0.020 |
Why?
|
| Anthraquinones | 1 | 2012 | 5 | 0.020 |
Why?
|
| Aggrecans | 1 | 2012 | 4 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2012 | 8 | 0.020 |
Why?
|
| Sepharose | 1 | 2012 | 6 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 137 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 66 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 76 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 526 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 9 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 22 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 10015 | 0.020 |
Why?
|
| Stifle | 1 | 2006 | 2 | 0.020 |
Why?
|
| Biological Dressings | 1 | 2006 | 1 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 2006 | 10 | 0.010 |
Why?
|
| Bandages | 1 | 2006 | 34 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 10 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 755 | 0.010 |
Why?
|
| Carbon | 1 | 1999 | 12 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 282 | 0.010 |
Why?
|